| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |